Related Content
November 1, 2022 โ Johnson & Johnson and Abiomed, a world leader in breakthrough heart, lung and kidney support ...
November 01, 2022
May 2, 2022 โ Johnson & Johnson MedTech have announced that Biosense Webster, Inc., a worldwide leader in the science ...
May 02, 2022
CERENOVUS Launches EMBOGUARD Balloon Guide Catheter to Use In the Treatment of Acute Ischemic Stroke
February 15, 2022 โ CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...
February 15, 2022
Feature | Coronavirus (COVID-19)| By Dave Fornell, Editor
(This story was updated May 7, 2021 in the last subheaded section) April 13, 2021 โ The U.S. Food and Drug ...
April 13, 2021
December 7, 2018 โ New data from the Phase 3 CASSINI study showed a 60 percent reduction of venous thromboembolism (VTE ...
December 07, 2018
March 15, 2018 โ Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who works in ...
March 15, 2018
January 5, 2017 โ A new report published by Allied Market Research forecasts that the global thrombectomy devices market ...
January 05, 2017March 9, 2015 โ Boston Scientific Corp. announced the settlement of the breach of merger agreement lawsuit brought by ...
March 09, 2015
January 5, 2011 โ Bayer HealthCare's oral anticoagulant tablet Xarelto (rivaroxaban) has been approved for use in the ...
January 05, 2012November 16, 2011 โ Johnson & Johnson Pharmaceutical Research & Development announced that adding oral rivaroxaban to ...
November 16, 2011ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now